Inflammatory Biomarkers and Respiratory Function in Liver Transplant Patients: Findings from a Nationwide Cohort Analysis - Summary - MDSpire

Inflammatory Biomarkers and Respiratory Function in Liver Transplant Patients: Findings from a Nationwide Cohort Analysis

  • By

  • Nicoline Arentoft

  • Julie Høgh

  • Hans-Christian Pommergaard

  • Andreas Dehlbæk Knudsen

  • Annette Dam Fialla

  • Paul Suno Krohn

  • Niels Kristian Aagaard

  • Jens-Ulrik Stæhr Jensen

  • Jesper Rømhild Davidsen

  • Michael Perch

  • Allan Rasmussen

  • Susanne Dam Nielsen

  • April 28, 2026

  • 0 min

Share

Objective:

To investigate the correlation between elevated inflammatory markers and impaired lung function in liver transplant recipients.

Key Findings:
  • 11.6% prevalence of airflow limitation and 24.5% prevalence of PRISm among participants.
  • Median FEV1 was 2790 mL (IQR 2230–3505 mL) and median FVC was 3680 mL (IQR 2980–3755 mL).
  • hs-CRP >3 mg/L was associated with increased odds of PRISm (aOR 2.08) and lower FEV1 and FVC.
Interpretation:

Elevated hs-CRP levels indicate a potential link between systemic inflammation and impaired lung function in liver transplant recipients, suggesting a need for monitoring and management of respiratory health in this population.

Limitations:
  • Cross-sectional design limits causal inference.
  • Potential confounding factors such as smoking status and BMI not fully accounted for despite adjustments.
Conclusion:

Elevated hs-CRP is associated with impaired lung function in liver transplant recipients, suggesting systemic inflammation may contribute to respiratory issues in this population.

Original Source(s)

Related Content